Molecular markers of thrombosis and their clinical significance
Pan, J.Y.; Zhang, Z.N.
Zhonghua Nei Ke Za Zhi 29(7): 395-397
1990
ISSN/ISBN: 0578-1426 PMID: 2282867 Document Number: 363190
Document emailed within 1 workday
Related Documents
Gschwandtner, M.E.; Eichinger, S.; Hütter, D.; Korninger, L.; Lechner, K.; Panzer, S.; Pabinger, I. 1996: Lupus anticoagulant and thromboembolism: evaluation of fibrinogen, natural inhibitors and molecular markers of thrombosis Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 7(3): 325-330Ohkura, H. 1993: Clinical significance of present tumor markers Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(7): 843-849
Castelli, M.; Sega, F.M.; Sciarretta, F.; Casale, V.; Coloni, F.; Sega, E. 1983: The biological and clinical significance of tumor markers in tissue extracts Cancer Detection and Prevention 6(1-2): 61-66
Barzell, W.E.; Whitmore, W.F. 1979: Clinical significance of biologic markers: Memorial Hospital experience Seminars in Oncology 6(1): 48-52
Hamakawa, H.; Takemura, M.; Sato, M.; Shinohe, R.; Koishi, H.; Furuta, N.; Ohta, H.; Koike, N.; Iwamoto, N.; Yamada, Y.; Wada, H.; Saito, K.; Seishima, M. 2003: Clinical significance of MMP-3 in patients with rheumatoid arthritis: comparison with other inflammatory markers(IL-6, IL-8) Rinsho Byori. Japanese Journal of Clinical Pathology 51(1): 13-18
Komatsu, H. 1987: Clinical significance of serum tumor markers (CEA, TPA, IAP and ferritin) in pulmonary tuberculosis Kekkaku: 62(1): 31-36
Hamakawa, H.; Takemura, M.; Sato, M.; Shinohe, R.; Koishi, H.; Furuta, N.; Ohta, H.; Koike, N.; Iwamoto, N.; Yamada, Y.; Wada, H.; Saito, K.; Seishima, M. 2003: Clinical significance of MMP-3 in patients with rheumatoid arthritis: comparison with other inflammatory markers(IL-6, IL-8) Rinsho Byori. Japanese Journal of Clinical Pathology 51(1): 13-18
Koppenhagen, K.; Tröster, E.; Matthes, M.; Häring, R. 1990: Prevention of thrombosis with low molecular weight heparin as the only substance and/or with DHE: results of clinical studies Langenbecks Archiv für Chirurgie. Supplement Ii Verhandlungen der Deutschen Gesellschaft für Chirurgie. Deutsche Gesellschaft für Chirurgie. Kongress 1990: 1163-1166
Barbui, T.; Finazzi, G.; Galli, M. 1997: Clinical significance and predictive value of laboratory tests in thrombosis associated with antiphospolipid antibodies Annali Italiani di Medicina Interna: Organo Ufficiale Della Societa Italiana di Medicina Interna 12(2): 76-83
Schwarz, B.; Mittelmeier, H. 1988: Initial clinical experiences with low molecular weight heparin in the prevention of thrombosis in orthopedic surgery Aktuelle Traumatologie 18(5): 226-232
Kuryliszyn-Moskal, A.; Klimiuk, P.Adrian.; Ciolkiewicz, M.; Sierakowski, S. 2008: Clinical significance of selected endothelial activation markers in patients with systemic lupus erythematosus Journal of Rheumatology 35(7): 1307-1313
Chorzelski, T.P.; Sulej, J. 1986: Clinical and pathogenetic significance of immunologic markers in gluten-dependent enteropathy (IgA-EmA) in dermatitis herpetiformis Przeglad Dermatologiczny 73(2): 108-114
Borris, L.C.; Lassen, M.R.; Jensen, H.P.; Andersen, B.S.; Poulsen, K.A. 1994: Perioperative thrombosis prophylaxis with low molecular weight heparins in elective hip surgery. Clinical and economic considerations International Journal of Clinical Pharmacology and Therapeutics 32(5): 262-268
Qu, Y.-m.; Liao, G.-q.; Liu, P.-h.; Wang, H.-m.; Liu, L.; Li, L.-l.; Xie, G.-q. 2010: Clinical significance of expressions of tumor markers in peripheral blood in non-small cell lung cancer Zhonghua Yi Xue Za Zhi 90(28): 1958-1962
Liubimova, N.V.; Kushlinskiĭ, N.E. 2001: Markers of bone remodeling: general concepts and clinical significance for skeletal lesions in oncologic patients Voprosy Onkologii 47(1): 18-33
Tan, C.-W.; Liu, C.-T.; Wu, Y.-H. 2009: The clinical significance of noninvasive inflammatory markers in exhaled breath condensate and induced sputum in persistent asthmatic patients Zhonghua Nei Ke Za Zhi 48(4): 299-303
Wei, N.; Qi, Y.; Yang, H.; Guo, L. 2018: Clinical observation of the efficacy of low-molecular-weight heparin calcium in prophylaxis of the deep venous thrombosis following the gynecological tumor surgery Pakistan Journal of Pharmaceutical Sciences 31(6(Special): 2835-2839
Yamagishi, Y.; Mikamo, H. 2014: Clinical Significance of Next-Generation Molecular Testing Systems for the Diagnosis of Infectious Diseases and Infection Control Rinsho Byori. Japanese Journal of Clinical Pathology 62(10): 1003-1012
Boccalon, H.; Elias, A.; Chalé, J.J.; Cadène, A.; Gabriel, S. 2000: Clinical outcome and cost of hospital vs home treatment of proximal deep vein thrombosis with a low-molecular-weight heparin: the Vascular Midi-Pyrenees study Archives of Internal Medicine 160(12): 1769-1773
Levine, M.N.; Planes, A.; Hirsh, J.; Goodyear, M.; Vochelle, N.; Gent, M. 1989: The relationship between anti-factor Xa level and clinical outcome in patients receiving enoxaparine low molecular weight heparin to prevent deep vein thrombosis after hip replacement Thrombosis and Haemostasis 62(3): 940-944